Trials / Sponsors / Cerenis Therapeutics, SA
Cerenis Therapeutics, SA
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | CER-001 Therapy as a Novel Approach to Treat Genetic Orphan Diseases Familial Hypoalphalipoproteinemia | Phase 3 | 2015-12-01 |
| Completed | CER-001 Atherosclerosis Regression ACS Trial Acute Coronary Syndromes | Phase 2 | 2015-08-01 |
| Completed | Exploratory Study of Plaque Regression Heterozygous Familial Hypercholesterolemia | Phase 2 | 2012-01-01 |
| Completed | Effect of CER-001 on Plaque Volume in Homozygous Familial Hypercholesterolemia (HoFH) Subjects Homozygous Familial Hypercholesterolemia | Phase 2 | 2011-11-01 |
| Completed | Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI Acute Coronary Syndrome | Phase 2 | 2011-03-01 |